These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10630552)

  • 1. Stopping anti-CMV therapy may be safe option for some HIV patients.
    Am J Health Syst Pharm; 2000 Jan; 57(1):21. PubMed ID: 10630552
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination HIV therapy and opportunistic infections of the eye in people with AIDS.
    Ash S
    Br J Ophthalmol; 1998 Sep; 82(9):981-2. PubMed ID: 9893581
    [No Abstract]   [Full Text] [Related]  

  • 4. Stopping CMV prophylaxis with HAART.
    TreatmentUpdate; 1998 Sep; 10(7):4-6. PubMed ID: 11365782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of cytomegalovirus retinitis in HIV-infected patients with low CD4 lymphocyte counts in Vietnam.
    Colby DJ; Vo DQ; Teoh SC; Tam NT; Liem NT; Lu D; Nguyen TT; Cosimi L; Pollack T; Libman H
    Int J STD AIDS; 2014 Jun; 25(7):516-22. PubMed ID: 24327723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomegalovirus infections in HIV infection].
    Matheron S
    Presse Med; 1997 Jan; 26 Suppl 1():13-5. PubMed ID: 9082435
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing trends in cytomegalovirus retinitis with highly active anti-retroviral therapy (HAART).
    Dhillon B; Ramaesh K; Leen C
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():275-6. PubMed ID: 10624419
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation of maintenance CMV therapy in HAART responders.
    Dunn JP
    Hopkins HIV Rep; 1999 May; 11(3):5. PubMed ID: 11367373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy.
    Jacobson MA; Stanley H; Holtzer C; Margolis TP; Cunningham ET
    Clin Infect Dis; 2000 Jan; 30(1):231-3. PubMed ID: 10619774
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrovascular changes misdiagnosed as cytomegalovirus retinitis reactivation in a patient with immune recovery.
    Robinson MR; Csaky KG; Lee SS; Masur H; Polis MA
    Clin Infect Dis; 2004 Jan; 38(1):139-41. PubMed ID: 14679460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganciclovir. A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS.
    Perry CM; Davis R
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):209-28. PubMed ID: 10169672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stricker RB; Goldberg B
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284794
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Stein DS
    Lancet; 1997 Aug; 350(9077):589-90. PubMed ID: 9284796
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Carr A; Cooper DA
    Lancet; 1997 Aug; 350(9077):589; author reply 590. PubMed ID: 9284795
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
    Jacobson MA; Zegans M; Pavan PR; O'Donnell JJ; Sattler F; Rao N; Owens S; Pollard R
    Lancet; 1997 May; 349(9063):1443-5. PubMed ID: 9164318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cessation of anti-CMV therapy in patients with CMV retinitis.
    Dunn JP
    Hopkins HIV Rep; 1998 Mar; 10(2):11. PubMed ID: 11365137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed clinical case definition for cytomegalovirus-immune recovery retinitis.
    Ruiz-Cruz M; Alvarado-de la Barrera C; Ablanedo-Terrazas Y; Reyes-Terán G
    Clin Infect Dis; 2014 Jul; 59(2):298-303. PubMed ID: 24771331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus Retinitis in a Human Immunodeficiency Virus-negative Cohort: Long-term Management and Complications.
    Jeon S; Lee WK
    Ocul Immunol Inflamm; 2015; 23(5):392-9. PubMed ID: 25760914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC; Benson CA; Johnson DW; Weinberg A
    Clin Infect Dis; 2001 Mar; 32(5):815-9. PubMed ID: 11229851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.